|
|
Profile
|
Delegates :
Mihir Pershad |
|
Incorporated :
August 28 , 2024 |
Paid in Capital :
Million yen |
Employees :
人 |
Address :
Inside Ryohei Yanagihara Tax Accountant Office 1F Yanagihara Oyama Building, 57-2 Oyamacho, Itabashi-ku TOKYO
〒173-0023
|
TEL/FAX :
/ |
URL：
https://umamibioworks.com/ |
Attachment :
 Umami_Overview.pdf [ 1.1MiB ] |
Mission/Background :
Umami Bioworks LLC is part of a global food-tech ecosystem led by Umami Bioworks, a Singapore-based biotechnology company founded in 2020. The group focuses on developing sustainable alternatives to conventional seafood by leveraging cellular agriculture and advanced bioengineering technologies.
Its mission is to transform how seafood is produced-shifting from ocean harvesting to scalable, cell-based production systems that reduce environmental impact, eliminate overfishing, and ensure food security.
|
|
Technology & Business
|
Umami Bioworks develops a platform for cell-cultivated seafood production, combining stem cell biology, bioprocess engineering, and machine learning. Its proprietary AI platform, ALKEMYST(TM), integrates genomic, metabolomic, and sensory datasets to accelerate R&D and optimize production processes.
The platform enables:
- Scalable production of cultivated seafood without animal harvesting
- Optimization of cell culture media and growth conditions
- Development of marine bioactives (e.g., PDRN) and functional ingredients
- Data-driven innovation across aquaculture and seafood supply chains
This integrated approach allows the company to build a B2B platform for sustainable marine biomanufacturing.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Cultivated Seafood Platform
|
Discovery
|
Cell-based seafood products derived from fish cells without harvesting animals
|
Scale-up production and commercialization with partners
|
ALKEMYST(TM) AI Platform
|
Launched
|
AI-driven platform integrating marine biological data for product development and process optimization
|
Expansion across global seafood value chains
|
Marine Bioactives (e.g., PDRN)
|
Discovery
|
Cell-cultured marine-derived functional ingredients for cosmetics and healthcare
|
Commercial supply and regulatory expansion
|
|
|
|
|
|
|
|
|
|
Highlights
|
- Founded in 2020 and headquartered in Singapore
- Developing cultivated seafood such as tuna, eel, and other high-demand species
- Collaborations with major industry players to accelerate commercialization (e.g., partnership for cultivated tuna development)
- Expansion into marine bioactives and AI-driven seafood innovation platforms
|
|
Hot news
|
Umami Bioworks is expanding its AI-based platform (ALKEMYST(TM)) beyond cultivated seafood into broader applications across aquaculture and the marine economy, enabling data-driven innovation and sustainability improvements at scale.
|
|
Alliance strategy
|
The company actively seeks partnerships with:
- Food and seafood companies (co-development and commercialization)
- Biotechnology and ingredient manufacturers
- Academic and research institutions
Key focus areas include:
- Scaling cultivated seafood production
- Expanding applications of marine bioactives
- Deploying AI-driven solutions across aquaculture and supply chains
|
|
|